摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

benzyl (2S,4S)-4-hydroxy-6-oxo-2-piperidinecarboxylate | 653589-27-6

中文名称
——
中文别名
——
英文名称
benzyl (2S,4S)-4-hydroxy-6-oxo-2-piperidinecarboxylate
英文别名
(2S,4S)-4-hydroxy-6-oxo-piperidine-2-carboxylic acid benzyl ester;benzyl (2S,4S)-4-hydroxy-6-oxopiperidine-2-carboxylate
benzyl (2S,4S)-4-hydroxy-6-oxo-2-piperidinecarboxylate化学式
CAS
653589-27-6
化学式
C13H15NO4
mdl
——
分子量
249.266
InChiKey
FGBLZCOEKYLXDT-QWRGUYRKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.37
  • 重原子数:
    18.0
  • 可旋转键数:
    3.0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    75.63
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    benzyl (2S,4S)-4-hydroxy-6-oxo-2-piperidinecarboxylate 在 palladium on activated charcoal 氢气 作用下, 以 四氢呋喃 为溶剂, 反应 8.0h, 以87%的产率得到(2S,4S)-4-hydroxy-6-oxo-piperidine-2-carboxylic acid
    参考文献:
    名称:
    为二氢乳清酶的活性位点设计的抑制剂。
    摘要:
    已经合成了四种新的化合物作为大肠杆菌中二氢乳清酶的潜在抑制剂。NMR光谱显示溶液中以水合物(7),烯醇(8)和烯醇盐(9)互变异构体的混合物形式存在4,6-二氧-哌啶-2(S)-羧酸(3)形式。发现该化合物在pH值为7-9时是相对于二氢乳清酸酯和硫代二氢乳清酸酯的竞争性抑制剂。76 microM的K(i)在pH7.0时最低,在此溶液中酮3和水合物形式的抑制剂3占优势。将化合物3还原为两个非对映体4-羟基衍生物(4和5),然后脱水得到烯烃衍生物1,2,3,6-四氢-6-氧吡啶-2-(S)-羧酸(6) 。在pH 8.0时,化合物4-6是硫代二氢乳清酸酯的竞争性抑制剂,K(i)值为3.0、1.6和2.3 mM。
    DOI:
    10.1016/j.bioorg.2005.08.001
  • 作为产物:
    参考文献:
    名称:
    Synthesis of Enantiopure 4-Hydroxypipecolate and 4-Hydroxylysine Derivatives from a Common 4,6-Dioxopiperidinecarboxylate Precursor
    摘要:
    tert-Butyl 2-substituted 4,6-dioxo-1-piperidinecarboxylates 4 have been prepared in good yield starting from Boc-Asp-(OBu)-Bu-t and other beta-amino acids. By analogy with chiral tetramic acids, their reduction by NaBH4 in CH2Cl2/AcOH afforded the corresponding cis-4-hydroxy delta-lactams in good yield and stereoselectivity (68-98% de). In the absence of the A(1,3) strain (reduction of 6-substituted 2,4-dioxo-1-piperidines 7), the cis-4-hydroxy isomer was still obtained as the major product but the de values were consistently lower. 4-Hydroxy-6-oxo-1,2-piperidinedicarboxylate 2a, readily accessible from Boc-Asp-OtBu (three steps, 63% overall yield), has proven to be an excellent building block for the synthesis of cis- and trans-4-hydroxypipecolates 17 and 24 (52 and 36% overall yield, respectively) and for the synthesis of a protected 4-hydroxylysine derivative 29 (41% overall yield).
    DOI:
    10.1021/jo0353886
点击查看最新优质反应信息

文献信息

  • Synthesis of Enantiopure 4-Hydroxypipecolate and 4-Hydroxylysine Derivatives from a Common 4,6-Dioxopiperidinecarboxylate Precursor
    作者:J. Marin、C. Didierjean、A. Aubry、J.-R. Casimir、J.-P. Briand、G. Guichard
    DOI:10.1021/jo0353886
    日期:2004.1.1
    tert-Butyl 2-substituted 4,6-dioxo-1-piperidinecarboxylates 4 have been prepared in good yield starting from Boc-Asp-(OBu)-Bu-t and other beta-amino acids. By analogy with chiral tetramic acids, their reduction by NaBH4 in CH2Cl2/AcOH afforded the corresponding cis-4-hydroxy delta-lactams in good yield and stereoselectivity (68-98% de). In the absence of the A(1,3) strain (reduction of 6-substituted 2,4-dioxo-1-piperidines 7), the cis-4-hydroxy isomer was still obtained as the major product but the de values were consistently lower. 4-Hydroxy-6-oxo-1,2-piperidinedicarboxylate 2a, readily accessible from Boc-Asp-OtBu (three steps, 63% overall yield), has proven to be an excellent building block for the synthesis of cis- and trans-4-hydroxypipecolates 17 and 24 (52 and 36% overall yield, respectively) and for the synthesis of a protected 4-hydroxylysine derivative 29 (41% overall yield).
  • Inhibitors designed for the active site of dihydroorotase
    作者:Yingchun Li、Frank M. Raushel
    DOI:10.1016/j.bioorg.2005.08.001
    日期:2005.12
    where the ketone and hydrate forms of the inhibitor 3 predominate in solution. Compound 3 was reduced to the two diastereomeric 4-hydroxy derivatives (4 and 5) and then dehydrated to yield the alkene derivative, 1,2,3,6-tetrahydro-6-oxopyridine-2(S)-carboxylic acid (6). Compounds 4-6 were competitive inhibitors versus thio-dihydroorotate at pH 8.0 with K(i) values of 3.0, 1.6, and 2.3 mM. Dihydroorotase
    已经合成了四种新的化合物作为大肠杆菌中二氢乳清酶的潜在抑制剂。NMR光谱显示溶液中以水合物(7),烯醇(8)和烯醇盐(9)互变异构体的混合物形式存在4,6-二氧-哌啶-2(S)-羧酸(3)形式。发现该化合物在pH值为7-9时是相对于二氢乳清酸酯和硫代二氢乳清酸酯的竞争性抑制剂。76 microM的K(i)在pH7.0时最低,在此溶液中酮3和水合物形式的抑制剂3占优势。将化合物3还原为两个非对映体4-羟基衍生物(4和5),然后脱水得到烯烃衍生物1,2,3,6-四氢-6-氧吡啶-2-(S)-羧酸(6) 。在pH 8.0时,化合物4-6是硫代二氢乳清酸酯的竞争性抑制剂,K(i)值为3.0、1.6和2.3 mM。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物